| [1] |
Alzheimer′s Disease International.Policy brief:the global impact of dementia 2013-2050[EB/OL].http://www.alz.co.uk/research/G8-policy-brief.
|
| [2] |
Alzheimer′s Disease International.World Alzheimer report 2015:the global impact of dementia[EB/OL].https://www.alz.co.uk/research/world-report-2015.
|
| [3] |
Guo JJ,Liao H.Development of drug for Alzheimer′s disease [J].J China Pharm Univ(中国药科大学学报),2010,41(5):395-400.
|
| [4] |
Citron M.Alzheimer′s disease:strategies for disease modification [J].Nat Rev Drug Discov,2010,9(5):387-398.
|
| [5] |
Cavalli A,Bolognesi ML,Minarini A,et al.Multi-target-directed ligands to combat neurodegenerative diseases [J].J Med Chem,2008,51(3):347-372.
|
| [6] |
De Freitas Silva M, Dias KST, Gontijo VS, et al. Multi-target directed drug as a modern approach for drug design toward Alzheimer′s disease:an update [J].Curr Med Chem,2018.doi: 10.2174/0929867325666180111101843.
|
| [7] |
Chen X, Mukwaya E, Wong MS, et al. A systematic review on biological activities of prenylated flavonoids[J].Pharm Biol,2014,52(5):655-660.
|
| [8] |
Sheng R,Lin X,Zhang J,et al.Design,synthesis and evaluation of flavonoid derivatives as potent AChE inhibitors[J].Bioorg Med Chem,2009,17(18):6692-6698.
|
| [9] |
Luo W,Su YB,Hong C,et al.Design,synthesis and evaluation of novel 4-dimethylamine flavonoid derivatives as potential multi-functional anti-Alzheimer agents[J].Bioorg Med Chem,2013,21(23):7275-7282.
|
| [10] |
Li RS,Wang XB,Hu XJ,et al.Design,synthesis and evaluation of flavonoid derivatives as potential multifunctional acetylcholinesterase inhibitors against Alzheimer′s disease[J].Bioorg Med Chem Lett,2013,23(9):2636-2641.
|
| [11] |
Li SY,Wang XB,Xie SS,et al.Multifunctional tacrine-flavonoid hybrids with cholinergic,beta-amyloid-reducing,and metal chelating properties for the treatment of Alzheimer′s disease[J].Eur J Med Chem,2013,69:632-646.
|
| [12] |
Sang Z,Li Y,Qiang X,et al.Multifunctional scutellarin-rivastigmine hybrids with cholinergic,antioxidant,biometal chelating and neuroprotective properties for the treatment of Alzheimer′s disease[J]. Bioorg Med Chem,2015,23(4):668-680.
|
| [13] |
Sang ZP,Qiang XM,Li Y,et al.Design,synthesis,and biological evaluation of scutellarein carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer′s disease[J]. Chem Biol Drug Des,2015,86(5):1168-1177.
|
| [14] |
Sang Z,Qiang X,Li Y,et al.Design,synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer′s disease[J]. Eur J Med Chem,2015,94:348-366.
|
| [15] |
Sang Z,Qiang X,Li Y,et al.Design,synthesis and evaluation of scutellarein-O-acetamidoalkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer′s disease[J]. Eur J Med Chem,2017,135:307-323.
|
| [16] |
Shi DH,Yan ZQ,Zhang LN,et al.A novel 7-O-modified derivative with acetylcholinesterase inhibitory effect,estrogenic activity and neuroprotective effect[J].Arch Pharm Res,2012,35(9):1645-1654.
|
| [17] |
Qiang X,Yuan W,Sang Z,et al.Synthesis and biological evaluation of genistein carbamate derivatives[J].Chin J Org Chem(有机化学),2013,33(3):621-629.
|
| [18] |
Qiang X,Sang Z,Yuan W,et al.Design,synthesis and evaluation of genistein-O-alkylbenzylamines as potential multifunctional agents for the treatment of Alzheimer′s disease[J]. Eur J Med Chem,2014,76:314-331.
|
| [19] |
Chen YP, Zhang ZY, Li YP, et al. Syntheses and evaluation of novel isoliquiritigenin derivatives as potential dual inhibitors for amyloid-beta aggregation and 5-lipoxygenase[J].Eur J Med Chem,2013,66:22-31.
|
| [20] |
Rampa A,Montanari S,Pruccoli L,et al.Chalcone-based carbamates for Alzheimer′s disease treatment [J].Future Med Chem,2017,9(8):749-764.
|
| [21] |
Jeon KH,Lee E,Jun KY,et al.Neuroprotective effect of synthetic chalcone derivatives as competitive dual inhibitors against μ-calpain and cathepsin B through the downregulation of tau phosphorylation and insoluble Aβ peptide formation [J].Eur J Med Chem,2016,121:433-444.
|
| [22] |
Wang L,Wang Y,Tian Y,et al.Design,synthesis,biological evaluation,and molecular modeling studies of chalcone-rivastigmine hybrids as cholinesterase inhibitors [J].Bioorg Med Chem,2017,25(1):360-371.
|
| [23] |
Xiao G, Li Y, Qiang X, et al. Design,synthesis and biological evaluation of 4′-aminochalcone-rivastigmine hybrids as multifunctional agents for the treatment of Alzheimer′s disease [J].Bioorg Med Chem,2017,25(3):1030-1041.
|
| [24] |
Belluti F,Rampa A,Piazzi L,et al.Cholinesterase inhibitors:xanthostigmine derivatives blocking the acetylcholinesterase-induced beta-amyloid aggregation [J].J Med Chem,2005,48(13):4444-4456.
|
| [25] |
Li Y,Qiang X,Luo L,et al.Synthesis and evaluation of 4-hydroxyl aurone derivatives as multifunctional agents for the treatment of Alzheimer′s disease [J].Bioorg Med Chem,2016,24(10):2342-2351.
|
| [26] |
Li Y,Qiang X,Luo L,et al.Aurone Mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition,anti-β-amyloid aggragation and neuroprotective properties for the treatment of Alzheimer′s disease [J].Eur J Med Chem,2017,126:762-755.
|
| [27] |
Javed H,Vaibhav K,Ahmed ME,et al.Effect of hesperidin on neurobehavioral,neuroinflammation,oxidative stress and lipid alteration in intracerebroventricular streptozotocin induced cognitive impairment in mice[J].J Neurol Sci,2015,348(1/2):51-59.
|
| [28] |
Chen X,Zenger K,Lupp A,et al.Tacrine-silibinin codrug shows neuro- and hepatoprotective effects in vitro and pro-cognitive and hepatoprotective effects in vivo[J].J Med Chem,2012,55(11):5231-5242.
|
| [29] |
Li Y,Qiang X,Luo L,et al.Multitarget drug design strategy against Alzheimer′s disease:homoisoflavonoid Mannich base derivatives serve as acetylcholinesterase and monoamine oxidase B dual inhibitors with multifunctional properties[J]. Bioorg Med Chem,2017,25(2):714-726.
|
| [30] |
Luo L,Li Y,Qiang X,et al.Multifunctional thioxanthone derivatives with acetylcholinesterase,monoamine oxidases and β-amyloid aggregation inhibitory activities as potential agents against Alzheimer′s disease[J]. Bioorg Med Chem,2017,25(6):1997-2009.
|
| [31] |
Wang SN,Li Q,Jing MH,et al.Natural xanthones from Garcinia mangostana with multifunctional activities for the therapy of Alzheimer′s disease[J].Neurochem Res,2016,41(7):1806-1817.
|
下载:
